The role of inflammation in the immune evasion of KRas

E Jane Homan1, Robert D Bremel1

  • 1ioGenetics LLC, Madison, WI, United States.

Insights

Inflammation-induced cathepsin B may degrade KRas mutant neoepitopes, hiding them from immune detection. This mechanism, involving cathepsin B, trypsin, and caspases, contributes to KRas-driven tumor immune evasion.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Ras family proteins (KRas, NRas, HRas) are mutated in over 25% of human tumors, primarily at G12 or G13.
  • KRas mutations are linked to inflammation, a known tumor precursor.
  • While KRas inhibitors show promise, KRas-driven tumors often resist immunotherapy.

Purpose of the Study:

  • To investigate the impact of cathepsin B on KRas neoepitopes.
  • To elucidate the role of inflammation-associated enzymes in KRas-driven tumor immune evasion.

Main Methods:

  • Literature review of cathepsin B, trypsin, and caspase interactions.
  • Analysis of cathepsin B's effect on KRas neoepitope peptides.
  • Schematic representation of proposed immune evasion mechanisms.

Main Results:

  • Cathepsin B, upregulated in tumors, may cleave KRas G12/G13 mutant neoepitopes.
  • This cleavage could prevent neoepitope binding to MHC I, rendering them immunologically invisible.
  • Interactions with trypsin and caspases may further facilitate immune evasion.

Conclusions:

  • Cathepsin B-mediated degradation of neoepitopes is a potential mechanism for KRas tumor immune evasion.
  • Inflammation and associated enzymes play a critical role in the immune escape of Ras family-driven cancers.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...